About this episode
FDA reviewers have strong incentive to restrict access to new drugs and other therapies until there is extensive evidence that the therapies are safe. These incentives work against patients suffering painful or terminal diseases that have no effective therapy. And throughout the COVID-19 pandemic the FDA was continually in the spotlight for its poorly handling many potential COVID-19 remedies.
Why do we have an FDA?
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time Free Thoughts publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Free Thoughts
Coming Soon: The Liberty Exchange
Free Thoughts
Fighting Government Secrecy (with Patrick Eddington)
Free Thoughts
When Is Democracy Undemocratic? (with Emily B. Finley)
Free Thoughts
Floods, Nuclear Power, and Wages (with Peter Van Doren)
Free Thoughts